Hyaluronic acid derivative and use thereof

a technology of hyaluronic acid and derivatives, which is applied in the field of hydrogels, can solve the problems of reducing the amount of hyaluronic acid, collagen, elastin, and other matrix polymers present in the skin, affecting the effect of skin elasticity, and affecting the appearance of skin,

Pending Publication Date: 2022-10-06
AMTIXBIO CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0014]Still yet another object of the present invention is to provide a method for improving skin wrinkles, comprising a step of injecting the filler composition into or under the skin of an individual.
[0023]In addition, the present invention provides a hyaluronic acid hydrogel prepared by crosslinking hyaluronic acid derivatives, each of which is represented by the above Formula 1, for example, a hyaluronic acid hydrogel in which crosslinking represented by the above Formula 2 or Formula 3 is formed between the hyaluronic acid derivatives; and a carrier for delivery of a bioactive substance, comprising the hyaluronic acid hydrogel. From this viewpoint, in an embodiment of the present invention, the carrier includes, but is not limited to, an antibody, an antibody fragment, a protein, a peptide, a polypeptide, a small molecule chemical compound, DNA and / or RNA, siRNA, a gene, and stem cells including adult stem cells, mesenchymal stem cells, or induced pluripotent stem cells (iPSCs). From this viewpoint, in another embodiment of the present invention, the carrier for delivery of a bioactive substance provides sustained release of the bioactive substance in vivo and ex vivo.
[0031]The technique for preparing a hyaluronic acid hydrogel according to the present invention is based on a hyaluronic acid derivative modified with a gallol group, and includes a step of crosslinking the hyaluronic acid derivatives under an appropriate oxidizing or specific pH condition. The present invention makes it possible to effectively control physical properties of a hydrogel such as crosslinking rate, elasticity, and adhesive strength depending on each crosslinking method, while allowing the hydrogel to have excellent biocompatibility.

Problems solved by technology

However, with aging, amounts of hyaluronic acid, collagen, elastin, and other matrix polymers present in the skin decrease.
Loss of this material results in wrinkles, holes, moisture loss, and / or other undesirable conditions that contribute to aging.
However, hyaluronic acid crosslinked products prepared by the methods in these patents have low stability against a hyaluronic acid-degrading enzyme and a high content of unreacted chemicals, which may cause bio-toxicity.
In addition, it is not easy to control crosslinking or physical properties of these products depending on an intended use.
Thus, there are limitations in applying such products to various medical materials.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Hyaluronic acid derivative and use thereof
  • Hyaluronic acid derivative and use thereof
  • Hyaluronic acid derivative and use thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation examples

Preparation Example 1

[0104]Preparation of Hyaluronic Acid Derivative Modified with Gallol Group

[0105]As illustrated in FIG. 1, a hyaluronic acid derivative modified with a gallol group according to the present invention was prepared. Specifically, hyaluronic acid (MW 200K, Lifecore Biomedical, LLC, IL, USA) was completely dissolved in water (TDW), and 1 equivalent of N-hydroxysuccinimide (NHS, Sigma-Aldrich, Inc., St. Louis, Mo., USA) and 1.5 equivalent of 1-(3-dimethylaminopropyl)-3-ehtylcarbodiimide hydrochloride (EDC, Thermo Scientific, Rockford, Ill., USA) were added thereto. After 30 minutes, 1 equivalent of 5′-hydroxydopamine (Sigma-Aldrich, Inc.) was added thereto as a PG moiety and the resultant was allowed to react at pH 4 to 4.5 for 24 hours. Reactants having two different molar ratios were used in the preparation of HA-PG conjugates (HA:EDC:NHS:PG=1:1.5:1:1 or 2:1.5:1:1). Then, EDC, NHS, and 5′-hydroxydopamine were removed by dialysis based on PBS and water (Cellu / Sep (tr...

preparation example 2

[0106]Preparation of Hyaluronic Acid Hydrogel

[0107]The hyaluronic acid derivatives of Preparation Example 1 were crosslinked to prepare a hyaluronic acid hydrogel, in which each crosslinking method using sodium periodate (NaIO4) as an oxidizing agent or sodium hydroxide (NaOH) as a pH adjusting agent (pH 8 to 9) was employed. Specifically, the hyaluronic acid derivatives were dissolved in PBS (1% (w / v), 2% (w / v)), and then crosslinking was allowed to proceed while performing mixing with 4.5 mg / ml of NaIO4 or 0.08 M NaOH at a volumetric ratio of 1.5:1 to 4:1 relative to the hyaluronic acid derivative solution. As illustrated in FIG. 3, through each of these crosslinking methods, a light brown-colored hyaluronic acid hydrogel or a blue-colored hyaluronic acid hydrogel was prepared.

[0108]In order to specifically identify crosslinking of the hyaluronic acid hydrogel, analysis with ultraviolet-visible spectroscopy (UV-vis) was performed. In a case of using NaIO4, as illustrated in FIG. 4...

example 1

[0109]Changes in Physical Properties of Hyaluronic Acid Hydrogel Depending on Crosslinking Method

[0110]In the present example, changes in physical properties of hyaluronic acid hydrogels, depending on difference in crosslinking method in Preparation Example 2, were compared. On the other hand, in the hydrogel preparation step, a molar concentration ratio of hyaluronic acid to 5′-hydroxydopamine (0.5×(HA:EDC:NHS:5′-hydroxydopamine=2:1.5:1:1), lx (HA:EDC:NHS:5′-hydroxydopamine=1:1.5:1:1)) could be used to adjust a rate of being substituted with a gallol group to 4% to 5% (0.5×) or 8% to 9% (1×) (not shown), and changes in physical properties of hydrogels depending on a degree of substitution of 5′-hydroxydopamine were also compared. Specifically, hydrogel formation and changes in elastic modulus over time were compared depending on crosslinking methods; and elasticity, adhesive strength, swelling, and degradation patterns depending on the crosslinking method and the degree of substitu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
temperatureaaaaaaaaaa
pHaaaaaaaaaa
Login to view more

Abstract

The present invention provides a hydrogel platform using, as a substrate, hyaluronic acid (HA) conjugated to a pyrogallol (PG) moiety. The HA-PG conjugate of the present invention can be rapidly crosslinked by two different methods, in each of which an oxidizing agent is used or a pH is adjusted. The hydrogel of the present invention can not only have excellent biocompatibility, but also can have efficiently controlled physical characteristics such as a crosslinking rate, elasticity, and adhesive strength, depending on each crosslinking method. On the basis of such excellent stability and functionality, the hydrogel of the present invention can be used in various fields including drug delivery, biopharmaceutical materials such as a wound healing agent or anti-adhesive agent, medicines, and cosmetic products.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]The present application is a divisional application of U.S. application Ser. No. 16 / 483,146 filed on Aug. 2, 2019, which is a U.S. national phase application of International Application No. PCT / KR2018 / 001473 filed on Feb. 2, 2018, which claims priority to Korean Application No. 10-2017-0014856 filed on Feb. 2, 2017 and Korean Application No. 10-2017-0014855 filed on Feb. 2, 2017. The applications are incorporated herein by reference.TECHNICAL FIELD[0002]The present invention relates to a hydrogel based on a hyaluronic acid derivative modified with a gallol group, and a use thereof.BACKGROUND ART[0003]Interest in functional biomaterials is increasing as markets for medical and biotech industries, cosmetics industry, and the like are rapidly expanding. In particular, development of biocompatible materials using natural polymers for which stability is ensured, rather than chemically synthesized polymers which may cause toxicity or side effe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61L27/20A61P17/02A61K38/18A61K47/36A61L27/52A61L27/54C08B37/08C08J3/075C08J3/24
CPCA61L27/20A61P17/02A61K38/1808A61K38/1891A61K47/36A61L27/52A61L27/54C08B37/0072C08J3/075C08J3/24C08J2305/08C08L5/08C08L2203/02A61L2400/06A61L2400/18A61L2430/34A61L2300/414
Inventor CHO, SEUNG WOOLEE, JUNG-SEUNGCHO, JUNG HOLEE, JONG-SEUNG
Owner AMTIXBIO CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap